NCT04635384 2026-03-18
ACROBAT
CareDx
Active not recruiting
Clinical Trials
30 trialsNCT06578351 2026-02-04
TRAM
Danone Asia Pacific Holdings Pte, Ltd.
Completed
NCT05923112 2025-12-05
BESPONSA Injection 1 mg Special Investigation
Pfizer
Completed
NCT06274788 2025-09-05
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Fresenius Kabi
Recruiting
NCT07145411 2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
NCT06476665 2025-08-19
A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.
Pfizer
Active not recruiting
NCT05541341 2025-06-06
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
Novartis
Recruiting
NCT05166135 2025-03-25
LOYAL
Pfizer
Completed
NCT05597085 2025-02-04
A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment
Pfizer
Completed
NCT04465370 2024-11-18
POGO
Edwards Lifesciences
Completed
NCT03154346 2024-09-19
Project Baseline Health Study
Baseline Study LLC
Active not recruiting
NCT04545333 2024-08-01
The clonoSEQ® Watch Registry
Adaptive Biotechnologies
Terminated
NCT05850013 2024-07-18
VISION-Jr
Xim Limited
Completed
NCT06392763 2024-04-30
Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data
Novartis
Completed
NCT05645133 2023-06-15
QPlus Pediatric Reference Interval
HemoSonics LLC
Terminated
NCT04357041 2023-05-17
CoVS
Clinical Nutrition Research Center, Illinois Institute of Technology
Completed
NCT04770922 2023-02-16
Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia
Cipherome, Inc.
Completed
NCT02003612 2022-11-07
Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia
Amgen
Completed
NCT04456959 2022-09-28
InO
Pfizer
Completed
NCT02010931 2022-09-15
Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients
Amgen
Completed
NCT04807478 2022-08-04
Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)
Fresenius Kabi
Withdrawn
NCT05349201 2022-07-01
CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)
Novartis
Completed
NCT02813252 2022-06-03
Long-Term Follow-up Study for Patients Previously Treated With JCAR015
Juno Therapeutics, a Subsidiary of Celgene
Completed
NCT04014764 2022-04-05
(ANSWer)
Notable Labs
Completed
NCT04836338 2021-04-08
GlideScope Spectrum Video Laryngoscope Blades and Stylet for Use in Neonate & Pre-Adolescent Populations
Verathon
Completed
NCT03515785 2018-12-14
A Study to Evaluate Effectiveness and Safety of Ponatinib in Patients With BCR-ABL Positive ALL in Standard Clinical Practice in Europe - "POSEIDON"
Incyte Corporation
Withdrawn
NCT03419494 2018-02-05
Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Unknown
NCT03141398 2017-07-26
CGMs
Hamad Medical Corporation
Withdrawn
NCT02188290 2015-10-06
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Kiadis Pharma
Completed
NCT00866671 2015-01-14
Observational Study of Nelarabine in Children and Young Adults
GlaxoSmithKline
Completed